COMP <GO>
OMCL vs IBM // RSI-14 & 200D SMA MOMENTUM
Omnicell Inc. ($0.001 par value) (NASDAQ) VS. International Business Machines Corporation (NYSE) • 15-METRIC TALLY: OMCL 1
— IBM 10
▲ RSI-14 & 200D SMA MOMENTUM LEADER: IBM
LAST: $36.65 (-0.62%) • MKT CAP: $1.68B
rsi-technicals
56.8
LAST: $257.81 (-0.18%) • MKT CAP: $244.11B
rsi-technicals
71.2
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OMCL VS. IBM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OMCL | IBM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 42.50% | 58.20% | -15.70 | IBM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.40% | 13.80% | -13.40 | IBM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 37.6x | 20.6x | +17.00 | IBM | /valuation <GO> |
| Free Cash Flow Yield | 5.16% | 4.96% | +0.20 | OMCL | /fcf-yield <GO> |
| Operating Margin | 0.40% | 19.10% | -18.70 | IBM | /operating-margins <GO> |
| Net Profit Margin | 0.20% | 15.70% | -15.50 | IBM | /net-margins <GO> |
| Revenue Growth (YoY) | 6.50% | 7.60% | -1.10 | IBM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.56% | -2.56 | IBM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.36 | 3.38 | -1.02 | IBM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 56.8 | 71.2 | -14.40 | IBM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.30 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.68B | $244.11B | -$242.42B | IBM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OMCL REV | IBM REV | OMCL GROSS % | IBM GROSS % | OMCL FCF | IBM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.18B | $67.53B | 42.5% | 58.2% | $86.9M | $12.10B |
| FY 2024 | $1.11B | $62.75B | 42.3% | 56.7% | $151.3M | $12.40B |
| FY 2023 | $1.15B | $61.86B | — | — | $181.1M | $11.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OMCL // BETA —
IBM // BETA 1.30